Biomerica (BMRA) Competitors $2.84 -0.04 (-1.39%) Closing price 04:00 PM EasternExtended Trading$2.88 +0.04 (+1.58%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BMRA vs. JATT, MTVA, OKUR, ITRM, RENB, MAAQ, TENX, LEXX, DARE, and KZRShould you be buying Biomerica stock or one of its competitors? The main competitors of Biomerica include JATT Acquisition (JATT), MetaVia (MTVA), OnKure Therapeutics (OKUR), Iterum Therapeutics (ITRM), Renovaro (RENB), Mana Capital Acquisition (MAAQ), Tenax Therapeutics (TENX), Lexaria Bioscience (LEXX), Dare Bioscience (DARE), and Kezar Life Sciences (KZR). These companies are all part of the "pharmaceutical products" industry. Biomerica vs. Its Competitors JATT Acquisition MetaVia OnKure Therapeutics Iterum Therapeutics Renovaro Mana Capital Acquisition Tenax Therapeutics Lexaria Bioscience Dare Bioscience Kezar Life Sciences Biomerica (NASDAQ:BMRA) and JATT Acquisition (NYSE:JATT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings. Do insiders and institutionals believe in BMRA or JATT? 22.3% of Biomerica shares are held by institutional investors. Comparatively, 48.0% of JATT Acquisition shares are held by institutional investors. 15.0% of Biomerica shares are held by insiders. Comparatively, 20.0% of JATT Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to BMRA or JATT? In the previous week, Biomerica's average media sentiment score of 0.00 equaled JATT Acquisition'saverage media sentiment score. Company Overall Sentiment Biomerica Neutral JATT Acquisition Neutral Is BMRA or JATT more profitable? JATT Acquisition has a net margin of 0.00% compared to Biomerica's net margin of -93.64%. JATT Acquisition's return on equity of -49.58% beat Biomerica's return on equity.Company Net Margins Return on Equity Return on Assets Biomerica-93.64% -98.97% -69.88% JATT Acquisition N/A -49.58%2.84% Which has higher earnings & valuation, BMRA or JATT? JATT Acquisition has lower revenue, but higher earnings than Biomerica. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiomerica$5.31M1.51-$4.97M-$2.32-1.22JATT AcquisitionN/AN/A$6.85MN/AN/A SummaryJATT Acquisition beats Biomerica on 6 of the 7 factors compared between the two stocks. Get Biomerica News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BMRA vs. The Competition Export to ExcelMetricBiomericaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.01M$2.52B$5.79B$10.49BDividend YieldN/A55.04%5.61%4.57%P/E Ratio-1.2223.26348.8926.87Price / Sales1.51563.63522.50164.46Price / CashN/A27.8326.0131.15Price / Book1.765.3615.536.51Net Income-$4.97M$32.95M$3.29B$271.42M7 Day Performance-5.02%3.96%200.87%3.68%1 Month Performance-18.16%5.27%184.38%8.07%1 Year Performance26.51%-0.72%325.51%29.68% Biomerica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BMRABiomerica0.2673 of 5 stars$2.84-1.4%N/A+28.3%$8.01M$5.31M-1.2260Positive NewsJATTJATT AcquisitionN/A$1.92-4.0%N/A-55.2%$33.12MN/A0.003High Trading VolumeMTVAMetaVia1.7854 of 5 stars$1.33-11.3%$7.50+463.9%N/A$32.19MN/A0.008Gap DownHigh Trading VolumeOKUROnKure Therapeutics2.7736 of 5 stars$2.37-0.8%$32.33+1,264.3%N/A$32.07MN/A-0.49N/AITRMIterum Therapeutics2.5207 of 5 stars$0.68-0.7%$9.00+1,224.9%-36.5%$32.04MN/A-0.8010RENBRenovaro0.4469 of 5 stars$0.18-4.0%N/A-66.3%$31.50MN/A-0.2420Upcoming EarningsMAAQMana Capital AcquisitionN/A$3.79-0.9%N/A+1,325.0%$30.79MN/A0.001Gap UpTENXTenax Therapeutics2.5041 of 5 stars$6.30+3.4%$18.00+185.7%+79.6%$28.73MN/A-6.859High Trading VolumeLEXXLexaria Bioscience3.2719 of 5 stars$1.46+12.3%$4.00+174.0%-62.0%$28.56M$615.92K-2.187Positive NewsDAREDare Bioscience2.1104 of 5 stars$2.10+3.4%$10.00+376.2%-35.0%$28.31M$10K-0.9830Positive NewsKZRKezar Life Sciences3.7552 of 5 stars$3.75-4.1%$9.00+140.0%-34.1%$27.46MN/A-0.3960Positive NewsGap Up Related Companies and Tools Related Companies JATT Acquisition Alternatives MetaVia Alternatives OnKure Therapeutics Alternatives Iterum Therapeutics Alternatives Renovaro Alternatives Mana Capital Acquisition Alternatives Tenax Therapeutics Alternatives Lexaria Bioscience Alternatives Dare Bioscience Alternatives Kezar Life Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BMRA) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomerica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomerica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMRA Stock Alerts